{"id":12706,"date":"2026-02-02T18:28:01","date_gmt":"2026-02-02T15:28:01","guid":{"rendered":"https:\/\/nesiller.com\/focus-tumor-specific\/"},"modified":"2026-10-20T20:27:30","modified_gmt":"2026-10-20T17:27:30","slug":"focus-tumor-specific","status":"publish","type":"page","link":"https:\/\/nesiller.com\/en\/oncology\/focus-tumor-specific\/","title":{"rendered":"Focus Tumor Specific"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Oncology<\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

Focus Tumor-Specific Panels<\/h1>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tTest brochure<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Tumor-Specific Panels<\/strong> analyze clinically relevant DNA<\/strong> and RNA<\/strong> variants associated with specific cancer types, enabling a comprehensive evaluation of the tumor’s molecular profile. The resulting genomic insights support the selection of personalized, targeted treatment strategies and contribute to informed clinical decision-making.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t
Feature<\/th>Details<\/th><\/tr><\/thead>
Sample<\/b><\/td>

FFPE (Tumor tissue)<\/span><\/p>

*(Bone marrow \/ blood\u00a0 samples for hematological panels)<\/span><\/i><\/p><\/td><\/tr>

Method<\/b><\/td>NGS (Next-Generation Sequencing)<\/span><\/td><\/tr>
Coverage<\/b><\/td>DNA \/ RNA\u00a0<\/span><\/td><\/tr>
Variants<\/b><\/td>SNV, Indel, CNV, Fusion<\/span><\/td><\/tr>
Duration<\/b><\/td>18 Days<\/span><\/td><\/tr><\/tbody><\/table>

*Broad genomic profiling panels are recommended for the assessment of genomic signatures and biomarkers such as TMB and HRDsig, as well as for monitoring resistance-associated alterations.<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

FOCUS Tumor-Specific Panels analyze clinically relevant DNA and RNA variants (SNV, indel, CNV, fusion) for specific cancer types in FFPE tumor tissue by NGS within 18 days, supporting personalized targeted treatment decisions.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":12725,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-12706","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/12706","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/comments?post=12706"}],"version-history":[{"count":25,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/12706\/revisions"}],"predecessor-version":[{"id":21747,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/12706\/revisions\/21747"}],"up":[{"embeddable":true,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/12725"}],"wp:attachment":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/media?parent=12706"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}